San Francisco, CA, United States of America

Deepak Srivastava

This inventor holds 9 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignees: The J. David Gladstone Institutes, The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone, University of California. Active years: 2014-2026.

USPTO Granted Patents = 9 (Patent Applications = 8)

% Patents Active = 55.6

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 14(Granted Patents)

Company Filing History:

5 out of 91

The J. David Gladstone Institutes

patents

4 out of 22

The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone

patents

1 out of 16,008

University of California

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661384 - METHODS FOR INDUCING CELL DIVISION OF POSTMITOTIC CELLS (2026-06-23),

2. 12599608 - Methods for treating cardiac valve disease (2026-04-14),

3. 11541102 - Methods for inducing cell division of postmitotic cells (2023-01-03),

4. 10669596 - Methods for inducing cell division of postmitotic cells (2020-06-02),

5. 9828585 - Methods for generating cardiomyocytes (2017-11-28),

6. 9517251 - Methods for generating cardiomyocytes (2016-12-13),

7. 9517250 - Methods for generating cardiomyocytes (2016-12-13),

8. 9364506 - Methods of modulating smooth muscle cell proliferation and differentiation (2016-06-14),

9. 8735568 - Methods of modulating smooth muscle cell proliferation and differentiation (2014-05-27),

Title: Innovator Spotlight: Deepak Srivastava

Introduction:

Deepak Srivastava is a distinguished inventor based in San Francisco, CA, with a remarkable portfolio of 7 patents to his name. His groundbreaking work in inducing cell division of postmitotic cells has far-reaching implications for the treatment of various diseases, from cardiovascular conditions to neural disorders.

Latest Patents:

Srivastava's latest patents focus on methods for inducing cell cycle reentry of postmitotic cells. These innovations not only offer insights into the rejuvenation of cells but also present promising avenues for addressing conditions such as cardiovascular diseases, neural disorders, hearing loss, and diabetes.

Career Highlights:

Throughout his career, Srivastava has made significant contributions to the field of biotechnology while working at The J. David Gladstone Institutes. His dedication to cutting-edge research and innovative discoveries has cemented his reputation as a pioneering figure in the industry.

Collaborations:

Srivastava's collaborative efforts with esteemed coworkers such as Masaki Ieda and Tamer M A Mohamed have led to the development of groundbreaking technologies and treatment modalities. Together, they have pushed the boundaries of scientific knowledge and paved the way for new advancements in healthcare.

Conclusion:

Deepak Srivastava's exemplary work as an inventor underscores his commitment to driving innovation and revolutionizing the field of biotechnology. His patents and research have the potential to transform the landscape of healthcare, offering new hope for individuals affected by a range of debilitating diseases.